{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:47:03Z","timestamp":1788378423855,"version":"build-2803163510"},"reference-count":51,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T00:00:00Z","timestamp":1680480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Academic Health System-Hamad Medical Corporation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by dysregulated growth and the proliferation of myeloid cells in the bone marrow caused by the BCR-ABL1 fusion gene. Clinically, CML demonstrates an increased production of mature and maturing granulocytes, mainly neutrophils. When a patient is suspected to have CML, peripheral blood smears and bone marrow biopsies may be manually examined by a hematologist. However, confirmatory testing for the BCR-ABL1 gene is still needed to confirm the diagnosis. Despite tyrosine kinase inhibitors (TKIs) being the mainstay of treatment for patients with CML, different agents should be used in different patients given their stage of disease and comorbidities. Moreover, some patients do not respond well to certain agents and some need more aggressive courses of therapy. Given the innovations and development that machine learning (ML) and artificial intelligence (AI) have undergone over the years, multiple models and algorithms have been put forward to help in the assessment and treatment of CML. In this review, we summarize the recent studies utilizing ML algorithms in patients with CML. The search was conducted on the PubMed\/Medline and Embase databases and yielded 66 full-text articles and abstracts, out of which 11 studies were included after screening against the inclusion criteria. The studies included show potential for the clinical implementation of ML models in the diagnosis, risk assessment, and treatment processes of patients with CML.<\/jats:p>","DOI":"10.3390\/diagnostics13071330","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T01:35:59Z","timestamp":1680572159000},"page":"1330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Applications of Machine Learning in Chronic Myeloid Leukemia"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3075-9600","authenticated-orcid":false,"given":"Mohamed","family":"Elhadary","sequence":"first","affiliation":[{"name":"College of Medicine, QU Health, Qatar University, Doha 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4927-9888","authenticated-orcid":false,"given":"Ahmed Adel","family":"Elsabagh","sequence":"additional","affiliation":[{"name":"College of Medicine, QU Health, Qatar University, Doha 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-8123","authenticated-orcid":false,"given":"Khaled","family":"Ferih","sequence":"additional","affiliation":[{"name":"College of Medicine, QU Health, Qatar University, Doha 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5983-0135","authenticated-orcid":false,"given":"Basel","family":"Elsayed","sequence":"additional","affiliation":[{"name":"College of Medicine, QU Health, Qatar University, Doha 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2266-7784","authenticated-orcid":false,"given":"Amgad M.","family":"Elshoeibi","sequence":"additional","affiliation":[{"name":"College of Medicine, QU Health, Qatar University, Doha 2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2613-9759","authenticated-orcid":false,"given":"Rasha","family":"Kaddoura","sequence":"additional","affiliation":[{"name":"Pharmacy Department, Heart Hospital, Hamad Medical Corporation (HMC), Doha 3050, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Akiki","sequence":"additional","affiliation":[{"name":"Diagnostic Genomic Division, Hamad Medical Corporation (HMC), Doha 3050, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Hematology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha 3050, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1144-8076","authenticated-orcid":false,"given":"Mohamed","family":"Yassin","sequence":"additional","affiliation":[{"name":"Hematology Section, Medical Oncology, National Center for Cancer Care and Research (NCCCR), Hamad Medical Corporation (HMC), Doha 3050, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer Statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/bjh.16599","article-title":"TARGET: A survey of real-world management of chronic myeloid leukaemia across 33 countries","volume":"190","author":"Turkina","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"341","author":"Faderl","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"10732748211009256","DOI":"10.1177\/10732748211009256","article-title":"Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients with Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project","volume":"28","author":"Yassin","year":"2021","journal-title":"Cancer Control"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1073274820976594","DOI":"10.1177\/1073274820976594","article-title":"Evaluation of Hepatitis B Reactivation among Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors","volume":"27","author":"Atteya","year":"2020","journal-title":"Cancer Control"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1007\/s00277-015-2325-z","article-title":"Natural course and biology of CML","volume":"94","author":"Chereda","year":"2015","journal-title":"Ann. Hematol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4065\/81.7.973","article-title":"Chronic myeloid leukemia: Diagnosis and treatment","volume":"81","author":"Cortes","year":"2006","journal-title":"Mayo. Clin. Proc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0609.1977.tb01474.x","article-title":"The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases","volume":"18","author":"Spiers","year":"1977","journal-title":"Scand. J. Haematol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10732748211038429","DOI":"10.1177\/10732748211038429","article-title":"Clinicopathological Variables and Outcome in Chronic Myeloid Leukemia Associated with BCR-ABL1 Transcript Type and Body Weight: An Outcome of European LeukemiaNet Project","volume":"28","author":"Abdulla","year":"2021","journal-title":"Cancer Control"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/17474086.2021.1875818","article-title":"Association of tuberculosis in patients with chronic myeloid leukemia: A treatment proposal based on literature review","volume":"14","author":"Iqbal","year":"2021","journal-title":"Expert Rev. Hematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.2017.18391","article-title":"Big Data and Machine Learning in Health Care","volume":"319","author":"Beam","year":"2018","journal-title":"JAMA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.aaa8415","article-title":"Machine learning: Trends, perspectives, and prospects","volume":"349","author":"Jordan","year":"2015","journal-title":"Science"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.media.2017.07.005","article-title":"A survey on deep learning in medical image analysis","volume":"42","author":"Litjens","year":"2017","journal-title":"Med. Image Anal."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-pathol-011811-120902","article-title":"Digital imaging in pathology: Whole-slide imaging and beyond","volume":"8","author":"Ghaznavi","year":"2013","journal-title":"Annu. Rev. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Auslander, N., Gussow, A.B., and Koonin, E.V. (2021). Incorporating Machine Learning into Established Bioinformatics Frameworks. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22062903"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: The convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine Learning in Medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"103627","DOI":"10.1016\/j.jbi.2020.103627","article-title":"A review on deep learning approaches in healthcare systems: Taxonomies, challenges, and open issues","volume":"113","author":"Shamshirband","year":"2021","journal-title":"J. Biomed. Inf."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e903","DOI":"10.1016\/j.clml.2021.06.025","article-title":"Accurate Machine-Learning-Based classification of Leukemia from Blood Smear Images","volume":"21","author":"Dese","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e14117","DOI":"10.1200\/JCO.2020.38.15_suppl.e14117","article-title":"Use of artificial intelligence to improve access to initial leukemia diagnosis in low- and middleincome countries","volume":"38","author":"Cerrato","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"vi11","DOI":"10.1093\/annonc\/mdw362.43","article-title":"Oncoguide system\u2014A computerized self-learning interactive assistance system for the diagnosis and treatment of CML\/MPN and MDS","volume":"27","author":"Hempel","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"6648574","DOI":"10.1155\/2020\/6648574","article-title":"IoMT-Based Automated Detection and Classification of Leukemia Using Deep Learning","volume":"2020","author":"Bibi","year":"2020","journal-title":"J. Healthc. Eng."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1182\/blood-2021-152447","article-title":"Automated peripheral blood cell differentiation using artificial intelligence-a study with more than 10,000 routine samples in a specialized leukemia laboratory","volume":"138","author":"Haferlach","year":"2021","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.compbiomed.2013.06.004","article-title":"Discrimination of malignant neutrophils of chronic myelogenous leukemia from normal neutrophils by support vector machine","volume":"43","author":"Ni","year":"2013","journal-title":"Comput. Biol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ajpath.2022.03.016","article-title":"The Diagnosis of Chronic Myeloid Leukemia with Deep Adversarial Learning","volume":"192","author":"Zhang","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/ajcp\/aqab086","article-title":"A Machine Learning Model to Successfully Predict Future Diagnosis of Chronic Myelogenous Leukemia with Retrospective Electronic Health Records Data","volume":"156","author":"Hauser","year":"2021","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Shanbehzadeh, M., Afrash, M.R., Mirani, N., and Kazemi-Arpanahi, H. (2022). Comparing machine learning algorithms to predict 5-year survival in patients with chronic myeloid leukemia. BMC Med. Inform. Decis. Mak., 22.","DOI":"10.1186\/s12911-022-01980-w"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1182\/blood-2018-99-117633","article-title":"Integration of multiple bioassays using machine learning to identify high-risk CP-CML patients treated with frontline imatinib","volume":"132","author":"Kok","year":"2018","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ajh.26047","article-title":"The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes","volume":"96","author":"Sasaki","year":"2021","journal-title":"Am. J. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring","volume":"93","author":"Jabbour","year":"2018","journal-title":"Am. J. Hematol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1182\/blood.V90.8.2863","article-title":"Recent advances in flow cytometry: Application to the diagnosis of hematologic malignancy","volume":"90","author":"Jennings","year":"1997","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1586\/14737159.2014.862153","article-title":"Recent advancements of flow cytometry: New applications in hematology and oncology","volume":"14","author":"Woo","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1002\/cyto.b.20363","article-title":"2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: Optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia","volume":"72","author":"Wood","year":"2007","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cyto.b.21764","article-title":"Flow Cytometry Assessment of CD26(+) Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia","volume":"96","author":"Raspadori","year":"2019","journal-title":"Cytom. B Clin. Cytom."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/leu.2015.261","article-title":"Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia","volume":"30","author":"Pfirrmann","year":"2016","journal-title":"Leukemia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1756-8722-6-54","article-title":"Biomarkers for determining the prognosis in chronic myelogenous leukemia","volume":"6","author":"Sweet","year":"2013","journal-title":"J. Hematol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia\u2014Advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_42","first-page":"24","article-title":"Molecular Monitoring of patients with Chronic Myeloid Leukemia (CML) in the state of Qatar: Optimization of Techniques and Response to Imatinib","volume":"2014","author":"Jewell","year":"2014","journal-title":"QSci. Connect"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrclinonc.2009.112","article-title":"Imatinib and beyond\u2014Exploring the full potential of targeted therapy for CML","volume":"6","author":"Kantarjian","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10732748211001796","DOI":"10.1177\/10732748211001796","article-title":"Assessment of Dasatinib Versus Nilotinib as Upfront Therapy for Chronic Phase of Chronic Myeloid Leukemia in Qatar: A Cost-Effectiveness Analysis","volume":"28","author":"Adel","year":"2021","journal-title":"Cancer Control"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1038\/s41375-020-0931-9","article-title":"The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia","volume":"34","author":"Pfirrmann","year":"2020","journal-title":"Leukemia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41375-021-01387-y","article-title":"Is the Sokal or EUTOS long-term survival (ELTS) score a better predictor of responses and outcomes in persons with chronic myeloid leukemia receiving tyrosine-kinase inhibitors?","volume":"36","author":"Zhang","year":"2022","journal-title":"Leukemia"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1002\/cncr.28106","article-title":"Trends in all-cause mortality among patients with chronic myeloid leukemia: A Surveillance, Epidemiology, and End Results database analysis","volume":"119","author":"Brunner","year":"2013","journal-title":"Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1200\/JCO.2015.66.2866","article-title":"Life Expectancy of Patients with Chronic Myeloid Leukemia Approaches the Life Expectancy of the General Population","volume":"34","author":"Bower","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1007\/s00277-015-2322-2","article-title":"A review of the European LeukemiaNet recommendations for the management of CML","volume":"94","author":"Baccarani","year":"2015","journal-title":"Ann. Hematol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood.V128.22.940.940","article-title":"Clinical application of artificial intelligence in patients with chronic myeloid leukemia in chronic phase","volume":"128","author":"Sasaki","year":"2016","journal-title":"Blood"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1182\/blood-2019-130148","article-title":"The impact of treatment recommendation by leukemia artificial intelligence program (LEAP) on survival in patients with chronic myeloid leukemia in chronic phase (CML-CP)","volume":"134","author":"Sasaki","year":"2019","journal-title":"Blood"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/7\/1330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:09:02Z","timestamp":1760123342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/13\/7\/1330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,3]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["diagnostics13071330"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics13071330","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,3]]}}}